R. Michael Carruthers

Insider Reports History

Location
Boulder, CO
Signature
/s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Michael Carruthers:

Company Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. Chief Financial Officer Common Stock 86,162 $1,153,915 $13.39 12 Aug 2025 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 26,875 $437,294 $18.91 12 Aug 2025 Direct
Reneo Pharmaceuticals, Inc. Director Class A Common Stock 4,939 $13,192 $2.67 04 Oct 2024 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 161,250 12 Aug 2025 Direct
OnKure Therapeutics, Inc. Director Stock Option (right to buy) 7,650 28 May 2025 Direct
Elevation Oncology, Inc. Director Stock Option (Right to Buy) 0 23 Jul 2025 Direct

Insider Reports Filed by R. Michael Carruthers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EWTX Edgewise Therapeutics, Inc. 12 Aug 2025 5 -$19,124 4 Chief Financial Officer 14 Aug 2025, 19:43
ELEV Elevation Oncology, Inc. 23 Jul 2025 5 $0 4 Director 24 Jul 2025, 16:15
ELEV Elevation Oncology, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:05
OKUR OnKure Therapeutics, Inc. 28 May 2025 1 $0 4 Director 30 May 2025, 16:50
EWTX Edgewise Therapeutics, Inc. 01 May 2025 3 -$21,621 4 Chief Financial Officer 07 May 2025, 21:08
EWTX Edgewise Therapeutics, Inc. 11 Oct 2024 2 +$49,700 4 Chief Financial Officer 16 Oct 2024, 16:23
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 5 $0 4 Director 08 Oct 2024, 19:21
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 Director 08 Oct 2024, 19:07
EWTX Edgewise Therapeutics, Inc. 20 Sep 2024 7 -$3,388,569 4 Chief Financial Officer 24 Sep 2024, 20:22
EWTX Edgewise Therapeutics, Inc. 12 Aug 2024 2 $0 4 Chief Financial Officer 14 Aug 2024, 16:13
ELEV Elevation Oncology, Inc. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:16
EWTX Edgewise Therapeutics, Inc. 01 May 2024 3 -$40,789 4 Chief Financial Officer 03 May 2024, 18:30
EWTX Edgewise Therapeutics, Inc. 23 Jan 2024 3 -$1,246,059 4 Chief Financial Officer 25 Jan 2024, 16:46
EWTX Edgewise Therapeutics, Inc. 17 Aug 2023 1 $0 4 Chief Financial Officer 18 Aug 2023, 20:13
EWTX Edgewise Therapeutics, Inc. 22 Jun 2023 2 +$7,100 4 Chief Financial Officer 26 Jun 2023, 16:28
ELEV Elevation Oncology, Inc. 16 Jun 2023 1 $0 4 Director 21 Jun 2023, 16:11
EWTX Edgewise Therapeutics, Inc. 01 May 2023 3 -$11,897 4 Chief Financial Officer 03 May 2023, 18:26
EWTX Edgewise Therapeutics, Inc. 08 Aug 2022 1 $0 4 Chief Financial Officer 10 Aug 2022, 17:42
ELEV Elevation Oncology, Inc. 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 18:41
EWTX Edgewise Therapeutics, Inc. 23 May 2022 2 $0 4 Chief Financial Officer 25 May 2022, 18:11
EWTX Edgewise Therapeutics, Inc. 01 May 2022 1 $0 4 Chief Financial Officer 03 May 2022, 16:14
EWTX Edgewise Therapeutics, Inc. 17 Aug 2021 1 $0 4 Chief Financial Officer 19 Aug 2021, 17:09
ELEV Elevation Oncology, Inc. 24 Jun 2021 0 $0 3 Director 24 Jun 2021, 18:07